根据一份提交给美国证券交易委员会(SEC)的文件显示,Tempest Therapeutics Inc. 将不会从售股股东出售公司股份的交易中获得任何收益。
该文件明确指出,此次股份出售所涉及的资金将完全归售股股东所有,公司自身不会从中取得任何财务进账。这一安排意味着,Tempest Therapeutics 的财务状况不会因此次股权变动而受到直接影响。
根据一份提交给美国证券交易委员会(SEC)的文件显示,Tempest Therapeutics Inc. 将不会从售股股东出售公司股份的交易中获得任何收益。
该文件明确指出,此次股份出售所涉及的资金将完全归售股股东所有,公司自身不会从中取得任何财务进账。这一安排意味着,Tempest Therapeutics 的财务状况不会因此次股权变动而受到直接影响。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.